« Back
Home /
Golimumab

Golimumab

Manufacturer	MedChem Express
Category	Antibodies In Vivo Antibodies
Type	Biosimilars
Specific against	other
Amount	5 mg
Item no.	HY-P99111-5mg
Targets	TNF
CASRN	476181-74-5
eClass 6.1	32160702
eClass 9.0	42030590
Available
Product Description	Golimumab (CNTO-148) is a potent human IgG1 TNFα antagonist monoclonal antibody. Golimumab has anti-inflammation activitity and inhibits IL-6 and IL-1β production. Golimumab acts via targeting and neutralizing TNF to prevent inflammation and destruction of cartilage and bone. Golimumab has the anticancer activity and induces cell apoptosis. Golimumab can be used for rheumatoid arthritis, Crohn's disease and cancer research[1][2][3].
StorageTemperature	Store at 4°C for 2 years, do not freeze
Shipping	Blue Ice
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	N/A
Clinical_Information	Launched
Manufacturers Research_Area	Cancer; Inflammation/Immunology
Solubility	H2O
Isoform	IL-1; IL-6; TNFRSF5/CD40
Pathway	Apoptosis; Immunology/Inflammation
Manufacturers Product type	Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Request delivery time